The Food and Drug Administration is entertaining the use of a drug commonly used to treat lung cancer, Opdivo, for use in the treatment of some qualifying mesothelioma patients. The current approval process in motion follows realization in the global medical community that Opdivo has proved to extend the lives of many patients suffering metastatic  Continue Reading »

Mesothelioma researchers and scientists, doctors, and patient advocates are working hard to eradicate mesothelioma as a fatal disease. They work around the world at an intense pace, developing new and more effective treatments, making new discoveries about the disease, and testing better detection methods that may help diagnose mesothelioma in its earlier stages—giving patients a  Continue Reading »

The U.S. Environmental Protection Agency (EPA) began its fight to ban asbestos-containing products beginning in 1971. The battle lasted all the way until 1990, with the EPA claiming a partial victory. Today’s strict regulations make it difficult for companies in the U.S. to use “harmful” levels of asbestos. However, according to the EPA, there are  Continue Reading »

It is estimated that 55 countries around the world have banned the use of asbestos. Others have imposed strict regulations and safety protocols on the use and eradication of the mineral. Still, at last count there were 193 independent countries on the planet, leaving 138 that have not imposed an all-out ban on asbestos. This  Continue Reading »

The 2014 International Symposium on Malignant Mesothelioma kicks off Wednesday, March 5, 2014 at the Hilton Alexandria Mark Center in Alexandria, Virginia. The Symposium, now in its 11th year, welcomes all attendees from patients and their families to advocates, members of the medical community, and more. The Symposium, which begins on Advocacy Day, will feature  Continue Reading »